Seeking Alpha

Genomic Health (GHDX +1.5%) moves up after beating Q4 estimates yesterday. Total revenue...

Genomic Health (GHDX +1.5%) moves up after beating Q4 estimates yesterday. Total revenue increased by 13% Y/Y, driven by a 10% rise in Oncotype DX(R) test results. For the year, the company expects FY13 EPS of $0.48 - $0.68, versus consensus of $0.28. It projects revenues to be $258 mln - $266 mln. The Street view is $263.90 mln in revenues.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector